Turkish Nephrology, Dialysis and Transplantation Journal - 2010; 19(1) http://www.tndt.org Turkish Nephrology, Dialysis and Transplantation Journal - RSS feed of 2010; 19(1) 1300-0705 January 2010 Turkish Nephrology, Dialysis and Transplantation Journal 1300-0705 <![CDATA[Turkish Society of Nephrology and World Kidney Day]]> http://www.tndt.org/text.php3?id=136 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 002 2010-01-01 001 Editorial <![CDATA[Diabetic Kidney Disease: Act Now or Pay Later]]> http://www.tndt.org/text.php3?id=120 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 006 2010-01-01 003 Review <![CDATA[Diyabetik Böbrek Hastalığı: Şimdi Harekete Geçin Yoksa Sonra Cezasını Ödeyin]]> http://www.tndt.org/text.php3?id=121 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 010 2010-01-01 007 Review <![CDATA[Low Levels of 1.25-Dihydroxy Vitamin D is associated with All-cause Mortality in Prevalent Hemodialysis Patients]]> http://www.tndt.org/text.php3?id=122 2 vitamin D level was significantly lower in diabetics. After two years of follow-up period, in crude analysis low serum 25-OH and 1.25 OH 2 vitamin D levels were associated with all cause mortality. In adjusted Cox-regression analysis, 1.25-OH 2 vitamin D level, but not 25-OH, was found as an independent predictor for all-cause mortality. Low 1.25-OH 2 vitamin D level was also found as an independent predictor for all-cause mortality in non-diabetic study group even after inclusion of time averaged vitamin Dtherapy dosage. Serum 1.25-OH vitamin D level is associated with all cause mortality in prevalant hemodialysis patients.]]> 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 016 2010-01-01 011 Original Article <![CDATA[The Effect of Different Antihypertensive Treatment Methods on Endothelial Functions in Patients With Chronic Renal Failure on Hemodialysis]]> http://www.tndt.org/text.php3?id=123 drug , n=30), hemodialysis patients (normotensive with strict volume control HD vc , n=30). von Willebrand factor (vWF), D-dimer, nitric oxide (NO), homocysteine and routine biochemical parameters were studied in all groups. RESULTS: Although the interdialytic weight gain of the hemodialysis patients using antihypertensive drugs was higher than hemodialysis patients applied strict volume control (p<0.001), the blood pressure of the drug users was within the acceptable levels. However, the levels of vWF, and, D–dimer in patients applied volume control were lower than that of HD drug CONCLUSION: In conclusion, although antihypertensive drugs can decrease elevated blood pressure to a limited extent in dialysis patients, they cannot improve the endothelial dysfunction. Elevated blood pressure and endothelial dysfunction are controlled effectively with volume control.]]> 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 022 2010-01-01 017 Original Article <![CDATA[Comparison of the Early Complications of Two Different Catheter Implantation Techniques]]> http://www.tndt.org/text.php3?id=124 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 028 2010-01-01 023 Original Article <![CDATA[Should Carnitine Treatment Be Used for All Hemodialysis Patients?]]> http://www.tndt.org/text.php3?id=125 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 034 2010-01-01 029 Original Article <![CDATA[The Comparison of Renal Osteodystrophy Parameters in Diabetic and Nondiabetic Patient with Moderate Renal Failure]]> http://www.tndt.org/text.php3?id=126 +2 ) and phosphorus (P) concentrations and alkaline phosphatase (ALP) activities and parathormone (PTH) concentration were measured. RESULTS: When the results of the patient group were compared with those of the control group, the mean serum Ca +2 concentration was found lower (p<0.05), the mean serum P, PTH concentration and ALP activity were found higher (p<0.001). There were no significant differences between the nondiabetic and the diabetic patient groups in terms of serum Ca +2 , P, PTH concentration and ALP activity (p>0.05). CONCLUSION: In conclusion, we did not find any significant difference between nondiabetic and diabetic subjects in terms of ROD parameters. Therefore, we speculate that diabetes may not create any risk in patients with moderate renal failure for ROD. However, further prospective and detailed studies comprising more patients also including histological examination are needed for clarifying this situation subject.]]> 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 039 2010-01-01 035 Original Article <![CDATA[The Effects of HCV Infection on Serum Lipid Profile in Hemodialysis Patients]]> http://www.tndt.org/text.php3?id=127 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 045 2010-01-01 040 Original Article <![CDATA[Use of Catheters for Vascular Access among Hemodialysis Patients: A Single Center's Experience]]> http://www.tndt.org/text.php3?id=128 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 051 2010-01-01 046 Original Article <![CDATA[Arterial Mycotic Aneurysm Rupture of Two Kidney Cadaveric Renal Transplantation Recipients Secondary to Enterococci and Candida]]> http://www.tndt.org/text.php3?id=129 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 054 2010-01-01 052 Case Report <![CDATA[Heparin-induced Thrombocytopenia As A Cause of Deep Venous Thrombosis: Effectiveness of Fondaparinux in Dialysis Patients]]> http://www.tndt.org/text.php3?id=130 3 /mm 3 on the first day of heparin infusion. Re-evaluation of the platelet count records showed that the number of platelets had dropped from 119 x10 3 /mm 3 to 80 x10 3 /mm 3 after LMWH, but this had gone unnoticed. Heparin was stopped and the patient was given Fondaparinux, a synthetic selective inhibitor of activated factor X, for alternative anticoagulation at a dose of 2.5 mg every other day subcutaenously and later started on peritoneal dialysis. The patient was discharged on warfarin after 20 days. Venous doppler revealed no thrombosis at the right main deep and surface femoral vein on the 32nd day. It seems that the deep venous thrombosis was related to Type II heparin-induced thrombocytopenia with localized vascular injury due to the hemodialysis catheter predisposing to the thrombotic event. In conclusion, heparininduced thrombocytopenia (HIT) can cause deep venous thrombosis, and should not be overlooked in patients with a reduced platelet count on dialysis. Use of Fondaparinux was effective in clearing the thrombosis.]]> 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 058 2010-01-01 055 Case Report <![CDATA[Cephoperazone-sulbactam Induced Coagulopathy in a Peritoneal Dialysis Patient]]> http://www.tndt.org/text.php3?id=131 th day after initial treatment. Prothrombin time, activated partial thromboplastin time, and INR were found to be 61.1 sec, 159.2 sec, and 5.55, respectively. She had no liver disease, obstructive jaundice, or other disease disrupting the intestinal absorption of vitamin K. Hepatitis markers were negative and liver function tests were normal. Warfarin and conventional heparin were also not used. The coagulation disorder was attributed to treatment with cephoperazonesulbactam and the treatment was discontinued. The bleeding stopped with intravenous vitamin K and fresh frozen plasma and the coagulation tests returned to normal range. Empirical meropenem and vancomycin were started due to ongoing fever. She was connected to a mechanical ventilator because of respiratory failure due to aspiration pneumonia. She later died due to aspiration pneumonia. Cephoperazone-sulbactam may lead to coagulopathy by affecting the metabolism of vitamin K. Clinicians should therefore be careful if they use this drug.]]> 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 061 2010-01-01 059 Case Report <![CDATA[A Case with Cyclosporine-Associated Thrombotic Microangiopathy in Early Stage after Kidney Transplantation Salvage with Tacrolimus and Plasma Exchange]]> http://www.tndt.org/text.php3?id=132 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 064 2010-01-01 062 Case Report <![CDATA[Management of Encrusted Ureteral Stent with Mini Percutaneous Nephrolithotomy in Patient with Kidney Transplantation]]> http://www.tndt.org/text.php3?id=133 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 068 2010-01-01 065 Case Report <![CDATA[An Insidious Disaster Composed of Sinusitis, Myocarditis, Lung Mass And Rapidly Progressive Glomerulonephritis: Wegener Granulomatosis]]> http://www.tndt.org/text.php3?id=134 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 072 2010-01-01 069 Case Report <![CDATA[(A)typical (Extra) Pulmonary Tuberculosis in Kidney Patients]]> http://www.tndt.org/text.php3?id=135 2010-01-01 Turkish Nephrology, Dialysis and Transplantation Journal 1 19 076 2010-01-01 073 Case Report